11/11/2021AffaMed Launches Digital Medicines Unit

11/11/2021PharmExec: China 2021 National Reimbursement Drug List Outlook (Update...

11/11/2021How Hong Kong Plays a Central Role in The Biotech Investment Boom

11/10/2021South China Province Plans $94 Million HPV Vaccination Pilot Program

11/10/2021NDRC and MIIT Jointly Issue the Implementation Plan for Promoting High...

11/10/2021Eli Lilly's Chinese NDA for RET Inhibitor Selpercatinib Accepted

11/10/2021CDR Solicits Comments for the Proposed Guidelines for Preparing Drug P...

11/10/2021CPhI Survey: US Pharma Growth to Exceed Both India and China in 2022

11/10/2021Merck KGaA Veteran Launches I/O Startup Marengo Therapeutics with $80M

11/9/2021Biosynth Carbosynth and Shengquan Acquire Kexing Biopharma's API Plant

11/9/2021PhIIC Reports Topline 2020 Data of Chinese Pharmaceutical Market

11/9/2021HUYABIO Announces the Exclusive License of the Wee1 Inhibitor from Sha...

11/9/2021China Reports Progress of New COVID-19 Antibody Drugs

11/9/2021Incidence of Guillain-Barré Syndrome (GBS) in China: A National Popul...

11/8/2021I-Mab and Roche Diagnostics Announce Strategic Collaboration to Co-Dev...

11/8/2021Ascentage and Pfizer Enter Clinical Trial Agreement to Evaluate Lisaft...

11/8/2021NHC Issues Action Plan to Improve Child Health

11/8/2021Half of Top 20 Pharma MNCs Participate CIIE, Showing Continued Commitm...

11/8/2021GlobalData: China's Accelerated Drug Approval Path Decelerate vs Other...

11/8/2021Nippon Shinyaku Establishes a Local Subsidiary in China

11/8/2021FT: US and China Urged to Collaborate on Cancer Drugs through New Init...

11/8/2021HitGen Teams Up with Cambridge Molecular for 'Deep Learning' Drug Dis...

11/8/2021ZJ Biotech and Boehringer Sign Biopharma Partnership at CIIE

11/5/2021CDE Solicits Comments on the Draft Measures for Suspension and Resumpt...

11/5/2021Recent Executive Moves

11/5/2021Biopharma Giant MSD Embraces New Opportunities at CIIE

11/5/2021Roche Showcases Cutting-Edge Healthcare Innovation Solutions at CIIE

11/4/2021NMPA Withdraws Approvals of 34 Domestic and Foreign Drug Products

11/4/2021MOFCOM Issues the Guidance Opinions for High Quality Development of th...

11/4/2021First Batch Of Drug Patent Linkage Complaints Filed At CNIPA

Page:164/776 Total number of articles:23266: [First][<<] [162] [163] [164] [165] [166] [>>] [End]